Since HER2/neu is particularly expressed in the carcinomas in situ, it is probably more involved in the initiation of carcinogenesis than in the growth of the already established tumors, hence showing no correlation with the Sdc1 in our research. Here, ERBB2 is linked to in situ carcinoma.